Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Single-Session Extraoral PBM After Third Molar Extraction: Complete Statistical AnalysisIndependent statistical analysis of Single-Session Extraoral PBM After Third Molar Extraction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT07522918).
- Single-Sided Deafness in the Medicare Population: Complete Statistical AnalysisIndependent statistical analysis of Single-Sided Deafness in the Medicare Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05250414).
- Single-Use Negative Pressure Wound Therapy for Free Flap Donor Sites: Complete Statistical AnalysisIndependent statistical analysis of Single-Use Negative Pressure Wound Therapy for Free Flap Donor Sites: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03340025).
- Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Sintilimab in Cancer of Unknown Primary: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab in Cancer of Unknown Primary: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05024968).
- Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SINUS-52Independent statistical analysis of Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898454).
- SIPIIndependent statistical analysis of Satisfaction of Limited English-Proficient Patients With Phone Interpretation Services Compared to In-Person Interpreters: A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- sipITIndependent statistical analysis of Feasibility of Using sipIT Tools to Increase Compliance With Fluid Consumption Guidelines in Urolithiasis-Prone Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SIPPYIndependent statistical analysis of Study to Investigate the Potential of Probiotics in Yogurt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00492583).
- Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01420965).
- SIRIndependent statistical analysis of Sugar-replacement Sweeteners, and Blood Sugar Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01128829).
- SirolimusIndependent statistical analysis of Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00388362).
- Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sirolimus for Autoimmune Disease of Blood Cells: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus for Autoimmune Disease of Blood Cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00392951).
- Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: Complete Statistical AnalysisIndependent statistical analysis of Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02357342).
- SIRTAIndependent statistical analysis of A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199): primary endpoint results, effect estimate with…
- SISIndependent statistical analysis of A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis): primary…
- SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF: Complete Statistical AnalysisIndependent statistical analysis of SIS Versus Office Hysteroscopy for Uterine Cavity Evaluation Prior to IVF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SISCAIndependent statistical analysis of Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST Elevation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SISTA-PIndependent statistical analysis of Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06307028).
- SISTErIndependent statistical analysis of Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00064662).
- SISTERSIndependent statistical analysis of SISTERS: Spasticity In Stroke Study - Randomized Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01032239).
- Sitagliptin Added-on to Insulin Study (0431-051): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Added-on to Insulin Study (0431-051): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395343).
- Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00449930).
- Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sitagliptin in Combination With Metformin and Sulfonylurea: Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin in Combination With Metformin and Sulfonylurea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00686634).
- Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant: Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01186562).
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): Complete Statistical AnalysisIndependent statistical analysis of Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01065766).
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): Complete Statistical AnalysisIndependent statistical analysis of Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- site markingIndependent statistical analysis of Visibility of Site Marking for Surgical Time Out With Two Different Skin Preparation Solutions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: Complete Statistical AnalysisIndependent statistical analysis of Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02978859).
- Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety: Complete Statistical AnalysisIndependent statistical analysis of Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and Satiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SiyakhanaIndependent statistical analysis of Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women: Complete Statistical AnalysisIndependent statistical analysis of SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: Complete Statistical AnalysisIndependent statistical analysis of SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Skin Surface and Intradermal Temperature Responses to Heat Stress: Complete Statistical AnalysisIndependent statistical analysis of Skin Surface and Intradermal Temperature Responses to Heat Stress: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06593067).
- SKYGGNIndependent statistical analysis of OCS-01 in Treating Inflammation and Pain in Post-cataract Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130802).
- Skylight 2Independent statistical analysis of A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2: primary endpoint results, effect estimate with confidence…
- SKYLINEIndependent statistical analysis of Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SLAMIndependent statistical analysis of Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SLAM-PDIndependent statistical analysis of Speech, Linguistic and Acoustic Markers in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04273672).
- SLD3Independent statistical analysis of Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SLEIndependent statistical analysis of A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689350).